Biomarin Pharmaceutical Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
© -
Okay. Welcome, everybody. I am Marty Auster, I'm the lead mid-cap biotech analyst here at Credit Suisse. Thank you for joining us today. We're going to be hosting now BioMarin for a fireside chat at the 29th Annual Credit Suisse Biotech Healthcare Conference. I am joined today by CEO, J.J. Bienaimé; and CFO, Brian Mueller.
And maybe just to kick off before we get into some of the details, J.J., if you could kind of just give us a little bit of the strategic overview of BioMarin and talk to us a little bit about your vision for the next kind of few years and kind of framework of BioMarin out in your mind. And also, again, I'd like to thank you guys for joining us today. J.J.?
©,-&
Thank you, Martin. So I'll be brief because we recently had our third quarter conference call. And the company obviously had a lot of news this year.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
